Kevin O’Leary Became Millionaire: A Quiet Payday
Kevin O’Leary’s $4.2 billion Softkey exit in 1999 turned him into a millionaire, but the moment was surprisingly low-...
What Crypto To Buy First As A Beginner
Beginners can start with a clear, low-risk entry into crypto. This intro explains selecting a primary asset, setting investment caps, and gradually expanding.
19,656 articles
Ethereum Price Prediction: Will Critical Support Hold?
Ethereum sits at a pivotal juncture around $2,160, with on-chain activity signaling caution and institutional demand ...
Arm Getting Into Silicon Could Change AI Chip Stocks
Arm is venturing into silicon design after decades as a licensing powerhouse. This bold shift could impact AI data ce...
This Fund Jumped 1,200% on AI Hype, Caution Warned
A private AI-focused fund has surged 1,200% on hype around Anthropic and SpaceX, drawing investor demand but also gro...
Mark Zuckerberg 25,000 Jobs: Leadership Under Probe
Meta has slashed about 25,000 jobs since 2022, with 700 more in Reality Labs this week. The moves spotlight a leaders...
Wall Street Just Piled Into AMD After Q1 Beat Upgrades
AMD delivered a strong Q1 FY2026, prompting a broad uprising in analyst targets. Nine firms boosted price targets as ...
Celanese (CE) 2026 Earnings: Outlook, Trends & Risks
Celanese (CE) stands at an inflection point as 2026 begins. This article breaks down the potential drivers behind cel...
Live: Rocket Earnings Tonight Set RKLB Path Higher
Rocket Lab faces a pivotal Q1 print this evening as analysts weigh Neutron timing against a record backlog. Guidance ...
RMTI 2026 Earnings Transcript: What Investors Need
A clear guide to reading RMTI's Q1 2026 earnings call, what the numbers mean, and how to spot the catalysts that can ...
President Donald Trump'S Pick to Lead the Fed: Market Impacts and Implications
The next Fed chair choice could redefine the market landscape. This article breaks down what president donald trump's...
Market Guru Yardeni Sees S&P 500 Soaring to 8,250 This Year
A famed market forecaster is signaling a bold by-year-end target for the S&P 500, driven by resilient earnings and a ...
Tiny Biotech Just Beat AbbVie's Drug: Risk for Investors?
A tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status